The role of immunoglobulin in optic neuromyelitis optica is to reduce the inflammation of the optic nerve, to promote the recovery of nerve function and to prevent the recurrence of the disease. Optic neuromyelitis optica is an autoimmune disease that mainly affects the optic nerve and spinal cord and is characterized by recurrent episodes of vision loss and limb weakness. The disease requires synergistic treatment with multiple medications, and immunoglobulins work differently at different times of the disease. In the acute phase of the disease, when high-dose hormone shocks are not effective, patients can be infused with high-dose immunoglobulin to reduce optic nerve inflammation.
During the remission period, patients can follow the doctor’s instructions to apply immunoglobulin to significantly reduce the probability of recurrence and promote the recovery of neurological function.
It is recommended that patients with optic neuromyelitis optica should consult a doctor in a timely manner to assess their condition, and strictly follow the doctor’s instructions on the use of medication, and not blindly use medication.